The effect of low oral doses of (-)-deprenyl and its metabolites on DSP-4 toxicity

Journal of Neural Transmission

Volumn 108, Issue 11, 2001, Pages 1239-1247

  Haberle, D ^a   Szoko E ^a   Halasz A S ^a   Magyar, K ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

( ) amphetamine; ( ) Deprenyl; ( ) methylamphetamine; DSP 4; Hippocampus; Neuroprotection

Indexed keywords

2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; AMPHETAMINE DERIVATIVE; CYTOCHROME P450; METHAMPHETAMINE; NORADRENALIN; SELEGILINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HIPPOCAMPUS; LOCUS CERULEUS; MALE; MOUSE; NERVE ENDING; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; NORADRENALIN BRAIN LEVEL; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTIPARKINSON AGENTS; BENZYLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MONOAMINE OXIDASE INHIBITORS; NEUROTRANSMITTER UPTAKE INHIBITORS; NOREPINEPHRINE; SELEGILINE;

EID: 0035207989     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020100002     Document Type: Article

References (28)

1. Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: Stereospecificity and independence from monoamine oxidase inhibition
2. DSP4-induced two-way active avoidance impairment in rats: Involvement of central and not peripheral noradrenaline depletion
3. Possible mechanism of action of (-)-deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders
4. Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: A longterm study
5. Effect of deprenyl on the progression of disability in early Parkinson's disease
6. Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons
7. Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B
8. Inhibition of MAO B, but not MAO A, blocks DSP-4 toxicity on central NE neurons
9. Acute action of DSP-4 on central norepinephrine axons: Biochemical and immunohistochemical evidence for differential effects
10. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP-4 on central noradrenaline neurons
11. Inhibition by deprenyl of dopamine uptake in rat striatum: A possible correlation between dopamine uptake and acetylcholine release inhibition
12. Amphetamine: Evaluation of d-and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex
13. Pharmacokinetics and metabolism of selegiline
14. DSP-4: A novel compound with neurotoxic effects on noradrenergic neurons of adult and developing rats
15. Some puzzling pharmacological effects of monoamine oxidase inhibitors
16. The neurotoxic compound N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride (DSP4) depletes endogenous norepinephrine and enhances release of [3H]norepinephrine from rat cortical slices
17. Behaviour of (-)-deprenyl and its analogues
18. The role of the metabolism of (-)-deprenyl in neuroprotection
19. The distribution of orally administered (-)-deprenyl-propynyl-14C and (-)-deprenyl-phenyl-3H in rat brain
20. Deprenyl is metabolized to methamphetamine and amphetamine in man
21. On the long-lasting inhibitory effect of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP 4) on the active uptake of noradrenaline
22. Deprenyl reduces the death of motoneurons caused by axotomy
23. Enantiomer identification of the major metabolites of (-)-deprenyl in rat urine by capillary electrophoresis
24. Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonism
25. Effect of MAO inhibitors on the uptake and metabolism of dopamine in rat and human brain
26. Metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor in rat: Relationship of metabolism to MAO-B inhibitory potency
27. Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus
28. Neurotoxicity of N-(2-chloroethyl)-N-ethyl-2-bromo-benzylamine hydrochloride (DSP 4) on noradrenergic neurons is mimicked by its cyclic aziridinium derivative